Orchid Pharma Ltd.
Snapshot View

View in App

Prices View details >>

388.00 0.00

21 March 2023, 04:01:00 PM
Volume: 352

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.orchidpharma.com
Market Cap 1,542.86 Cr.
Enterprise Value(EV) 1,910.30 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -4.75 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-12
Industry PE 31.71 Trailing Twelve Months Ending 2022-12
Book Value / Share 155.99 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.42 Calculated using Price: 378.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 4.08 Cr. 40,816,400 Shares
FaceValue 10
Company Profile
Orchid Chemicals & Pharmaceuticals (Orchid) is pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. The company was Incorporated in the year 1992 as a 100% export-oriented unit (EOU).

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
-2.59%
1 Month
-8.32%
3 Month
-0.44%
6 Month
+15.34%
1 Year
+36.67%
2 Year
-77.85%
5 Year
+2850.57%
10 Year
+494.18%

Ratios View Details >>

9 years 2013-09 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -74.06 -55.58 -147.51 -423.17 -13.43 -8.75
Return on Capital Employed (%) -1.48 4.17 -0.06 -6.93 -3.46 3.08 -6.47 -3.53 -2.32
Return on Assets (%) -13.04 -4.53 -7.05 -13.59 -10.88 2.24 -5.78 -7.06 -4.85

Balance Sheet View Details >>

Particulars 10 years 2013-09 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 380 329 49 -388 -792 -704 766 653 647 622
Non Curr. Liab. 1,064 2,609 2,475 2,205 1,905 1,436 519 442 222 223
Curr. Liab. 3,206 1,123 1,338 1,541 2,013 2,346 175 142 241 320
Minority Int. 1
Equity & Liab. 4,651 4,061 3,862 3,358 3,125 3,077 1,460 1,237 1,111 1,165
Non Curr. Assets 3,550 2,783 2,611 2,479 2,446 2,310 891 687 661 670
Curr. Assets 1,101 1,278 1,251 879 679 767 569 550 450 496
Misc. Exp. not W/O
Total Assets 4,651 4,061 3,862 3,358 3,125 3,077 1,460 1,237 1,111 1,165

Profit Loss View Details >>

Particulars 10 years 2013-09 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 1,948 1,747 873 797 683 600 484 450 560 634
Other Income 41 42 25 19 20 17 24 15 9 19
Total Income 1,988 1,789 898 816 703 617 508 465 569 654
Total Expenditure -1,837 -1,429 -703 -709 -659 -612 -515 -399 -505 -566
PBIDT 151 360 196 106 45 5 -7 66 64 88
Interest -523 -537 -294 -331 -310 -7 -6 -52 -33 -29
Depreciation -252 -325 -145 -141 -133 -130 -118 -109 -87 -74
Taxation 13 191 17 48 46
Exceptional Items 51 113 -53 -173 201
PAT -560 -197 -279 -490 -353 69 -131 -95 -57 -15
Minority Interest 2 1
Share Associate 0 -4 -2
Other Related Items
Consolidated Net Profit -558 -197 -279 -490 -353 70 -131 -117 -2 -19
Adjusted EPS -79 -23 -31 -55 -40 8 -32 -29 0 -5

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-09 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 737 168 -369 212 317 9 12 81 24 92
Cash Fr. Inv. -293 -986 1,334 -1 -9 -28 45 167 67 113
Cash Fr. Finan. -480 664 -597 -286 -366 33 0 -250 -165 -217
Net Change -36 -153 367 -76 -58 15 57 -2 -74 -11
Cash & Cash Eqvt 177 23 391 315 257 35 92 90 16 4

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 98.07 98.07 90.00 90.00 90.00 90.00 89.96 89.96 89.96
Public 1.93 1.93 10.00 10.00 10.00 10.00 10.04 10.04 10.04
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.04 0.04 32.68 32.68 32.68 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 03 Mar 2023
Announcement Under Regulation 30 (LODR)- Update
Announcement under Regulation 30 (LODR)- Update
Wed, 22 Feb 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Investor call/earning call held on February 17 2023.
Fri, 17 Feb 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor Presentation - February 17 2023

Technical Scans View Details >>

Mon, 20 Mar 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 230,636.07 956.20 -0.5%
Divi's Laboratories Ltd. 74,303.33 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. 73,967.90 4,419.30 -0.5%
Cipla Ltd. 70,000.14 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. 61,905.77 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. 51,514.78 1,518.00 -0.3%
Zydus Lifesciences Ltd. 48,165.73 477.95 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 54.76 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 31.06 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.25 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-12 26.53 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.95 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.90 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.34 477.95 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.17 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 5.98 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.35 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-12 3.08 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.04 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.07 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.79 477.95 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 0.04 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 477.95 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 13.10 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 477.95 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 13.10 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 477.95 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 477.95 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 477.95 +0.4%

FAQ's On Orchid Pharma Ltd.

What is Orchid Pharma share price?
Can I buy Orchid Pharma shares now?
What is the Market Cap of Orchid Pharma?
What are the key metrics to analyse Orchid Pharma?
What is the 52 Week High and Low of Orchid Pharma?
What is the trend of Orchid Pharma share price?